Filing Flows › QuidelOrtho (QDEL) › Q2 2026 › vs Q1 2026
QuidelOrtho (QDEL) Q2 2026 vs Q1 2026 (quarter over quarter)
QuidelOrtho's revenue rose $11.1M (+2%) from $620M in Q1 2026 to $631M in Q2 2026.
QuidelOrtho, Q2 2026: revenue $631M (+3% year over year), operating margin -3.5%, net loss $92.9M, operating cash flow −$111M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $631M | $620M | $11.1M | +2% |
| Net loss | $92.9M | $91.8M | $1.1M | +1% |
| Costs & expenses | $724M | $712M | $12.2M | +2% |
| Operating costs | $653M | $652M | $1.1M | +0.2% |
| Interest & other, net | $59.4M | $47.7M | $11.7M | +25% |
| Income tax | $11.7M | $12.3M | −$600K | -5% |
| Cost of revenue | $358M | $356M | $2.0M | +0.6% |
| Research & development | $48.7M | $44.9M | $3.8M | +8% |
| SG&A | $190M | $199M | −$9.6M | -5% |
| Other operating costs | $56.3M | $51.4M | $4.9M | +10% |
| Operating cash sources | $239M | $157M | $82.7M | +53% |
| Depreciation & amortization | $117M | $113M | $3.8M | +3% |
| Share-based compensation | $12.0M | $10.7M | $1.3M | +12% |
| Cash used in operations | $111M | $33.0M | $77.6M | +235% |
| Net loss absorbed | $92.9M | $91.8M | $1.1M | +1% |
| Working capital & other | $146M | $64.8M | $81.6M | +126% |
Questions
How much did QuidelOrtho's revenue grow quarter over quarter in Q2 2026?
QuidelOrtho's revenue rose $11.1M (+2%) from $620M in Q1 2026 to $631M in Q2 2026.